anemodeanin a has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Dai, X; Wang, B; Wang, W; Wu, B; Ye, L; Zhu, J | 1 |
| Hou, X; Liu, Y; Ouyang, Z; Peng, F; Shen, C; Shu, M; Wang, L; Wang, X; Yang, M; Zhang, LW; Zhao, B; Zhao, S | 1 |
2 other study(ies) available for anemodeanin a and Glioblastoma
| Article | Year |
|---|---|
Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Topics: Animals; beta Catenin; Brain Neoplasms; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Mice; Neovascularization, Pathologic; Saponins; Vascular Endothelial Growth Factor A; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Raddeanin a Suppresses Glioblastoma Growth by Inducing ROS Generation and Subsequent JNK Activation to Promote Cell Apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Enzyme Activation; Glioblastoma; Humans; MAP Kinase Kinase 4; Neoplasm Proteins; Reactive Oxygen Species; Saponins | 2018 |